Kaurenoic Acid: Sustainable Bioactive with Healing Benefits
In a groundbreaking study, researchers led by Pimentel, Teixeira, and Soares have unveiled remarkable insights into kaurenoic acid, a compound derived from the by-products of synthetic biology. Their work not…
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced it has completed the acquisition of ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies.…
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer
AGOURA HILLS, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) in collaboration with the Brush and Key Foundation, today announced the publication of a peer-reviewed research…
LifeNet Health Advances Regenerative Medicine with the Acquisition of Biopreservation Leader, Tissue Testing Technologies
, /PRNewswire/ — LifeNet Health, a global leader in regenerative medicine, has acquired Tissue Testing Technologies LLC (T3), a biotechnology company specializing in biopreservation. T3 ‘s advanced proprietary technologies and…
Pivot Bio Announces Additions to Senior Management
New Team Members Bring Experience and Strategic Vision , /PRNewswire/ — Pivot Bio, one of the world’s leading innovative agtech companies, today announced six seasoned professionals have joined its senior…
SPR Reaches Milestone 50,000th Implant of the SPR® SPRINT® PNS System
SPR announces 50,000 SPRINT PNS implants Dr. Christopher Gilmore and team performed the milestone 50,000th SPRINT PNS implant. CLEVELAND, Dec. 15, 2025 (GLOBE NEWSWIRE) — SPR announced that it has…
BetaGlue Therapeutics Receives Belgium Ministry of Health Approval for YntraDose Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
MILAN, Dec. 15, 2025 (GLOBE NEWSWIRE) — BetaGlue® Therapeutics (“BetaGlue” or the “Company”), a pioneering Italian clinical-stage oncology company developing an innovative radiotherapy solution for the targeted treatment of solid…
Helio Genomics Forms Strategic Partnership with LiverRight Aimed at Broadening Nationwide Access to Early Liver Cancer Detection
Combining breakthrough blood-based test with same-week access to board-certified hepatologists in all 50 states , /PRNewswire/ — Helio Genomics (“Helio” or “the Company”), an AI-driven techbio company specializing in diagnostics…
Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research
Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research and development programs , /PRNewswire/ — Lunit (KRX:328130), a…
Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Carcinoma
Promising data show a median overall survival of 18.6 months, with 40% of patients alive at 2 years. Results suggest that nuclear GSK-3β expression may help identify patients most likely…